文献速递腹部泌尿生殖CT

可切除结直肠癌患者分期CT检出肾上腺结节的恶性肿瘤发生率

Incidence of malignancy in adrenal nodules detected on staging CTs of patients with potentially resectable colorectal cancer.
PubMed 文献 · Eur Radiol · 2022-06-03

回顾性分析6474例可切除结直肠癌患者分期CT,肾上腺结节患病率5.6%(363/6474),其中恶性结节占0.8%(3/363),结直肠癌肾上腺转移占0.3%(1/363),6.1%(22/363)行额外肾上腺检查。官方报告记录结节患病率1.9%(125/6474),结论认为此类结节极少为恶性。

要点

  • 可切除结直肠癌分期CT中肾上腺结节患病率5.6%,但恶性比例仅0.8%。
  • 363例结节患者中仅1例为结直肠癌肾上腺转移(0.3%)。
  • 官方报告对肾上腺结节的记录率(1.9%)低于回顾性阅片(5.6%)。

核心结论

  • 在可切除结直肠癌患者的分期CT中检出的肾上腺结节极少为恶性(3/363,0.8%)。

研究设计与样本

  • 回顾性研究,纳入2003年5月至2018年12月间6474例(中位年龄65岁,四分位距56-73岁,男3902例)接受结直肠癌分期CT、具有潜在可切除结直肠癌(包括可切除肝或肺转移)的患者,通过回顾性CT图像复习识别肾上腺结节并以官方CT报告行二次分析。

关键影像表现/征象

  • 回顾性CT图像复习检出肾上腺结节(≥10 mm)363例(5.6%,95%CI 5.1-6.2)。
  • 363例肾上腺结节中恶性结节3例(0.8%,95%CI 0.2-2.4),结直肠癌肾上腺转移1例(0.3%,95%CI 0.0-1.5)。
  • 363例中22例(6.1%,95%CI 3.8-9.0)接受了额外肾上腺检查(活检或影像学检查)。

诊断标准与关键数值

  • 回顾性图像复习中肾上腺结节定义为≥10 mm。
  • 回顾性图像复习:恶性结节比例0.8%(3/363,95%CI 0.2-2.4),结直肠癌肾上腺转移比例0.3%(1/363,95%CI 0.0-1.5),额外肾上腺检查比例6.1%(22/363,95%CI 3.8-9.0)。
  • 官方CT报告:肾上腺结节患病率1.9%(125/6474,95%CI 1.6-2.3),恶性结节比例1.6%(2/125,95%CI 0.2-5.7),结直肠癌肾上腺转移比例0%(0/125,95%CI 0.0-2.9),额外肾上腺检查比例10.4%(1/125,95%CI 5.7-17.1)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To measure the prevalence of adrenal nodules detected on staging CT in patients with resectable colorectal cancer, and the proportion of patients with malignant nodules among them.

METHODS: This retrospective study included 6474 patients (median age, 65; interquartile range, 56-73; 3902 men) who underwent staging CT for colorectal cancer between May 2003 and December 2018. The patients had potentially resectable colorectal cancer, including resectable hepatic or pulmonary metastases. Through retrospective CT image review, patients with adrenal nodules were identified for the prevalence of adrenal nodule. Among patients with adrenal nodules, per-patient proportions of malignant nodules, adrenal metastasis from colorectal cancer, and additional adrenal examinations (biopsy or imaging tests) were measured. A secondary analysis was performed using data from the official CT reports.

RESULTS: The prevalence of adrenal nodules was 5.6% (363 of 6474; 95% CI: 5.1, 6.2). The proportions of malignant nodules and adrenal metastasis from colorectal cancer were 0.8% (3 of 363; 0.2, 2.4) and 0.3% (1 of 363; 0.0, 1.5), respectively. 6.1% (22 of 363; 3.8, 9.0) of the patients underwent additional adrenal examination. According to official CT reports, the prevalence of adrenal nodules and proportions of malignant nodules, adrenal metastasis from colorectal cancer, and additional adrenal examination were 1.9% (125 of 6474; 1.6, 2.3), 1.6% (2 of 125; 0.2, 5.7), 0% (0 of 125; 0.0, 2.9), and 10.4% (1 of 125; 5.7, 17.1), respectively.

CONCLUSION: Adrenal nodules detected in staging CTs in patients with otherwise resectable colorectal cancers are rarely malignant.

KEY POINTS: • Among 6474 patients who underwent staging CT and had potentially resectable colorectal cancer, 363 had adrenal nodules (≥ 10 mm) detected in retrospective CT image review. • Three out of the 363 patients with adrenal nodules detected on staging CT had malignant adrenal nodules, one of whom had metastasis from colorectal cancer.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Kim, Lee, Chang, et al. Incidence of malignancy in adrenal nodules detected on staging CTs of patients with potentially resectable colorectal cancer. Eur Radiol. 2022. PMID: 35665845. doi:10.1007/s00330-022-08892-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。